United Therapeutics Corp (UTHR): EBITDA
$1.58B
Year ended 2025-12-31
$1.49B
Trailing 12 months to 2026-06-30
+15.2%
3-year compound annual growth
+19.7%
5-year compound annual growth
+8.0%
10-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.58B | +8.9% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $1.45B | +17.1% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $1.24B | +20.1% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $1.03B | +70.2% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $605.80M | -5.9% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $643.50M | n/m | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | -$141.70M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $841.30M | -0.5% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $845.90M | -22.6% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $1.09B | +49.4% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $731.90M | +28.2% | 2018-02-21, From 2015-01-01 |
| 2014-12-31 | $571.00M | +76.4% | 2017-02-22, From 2014-01-01 |
| 2013-12-31 | $323.76M | -27.9% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $448.79M | +32.7% | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $338.32M | +78.8% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $189.23M | +409.4% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $37.15M | n/m | 2012-02-28, From 2009-01-01 |
| 2008-12-31 | -$77.52M | n/a | 2011-02-24, From 2008-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.58B | +8.9% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $489.04M | -15.8% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $557.24M | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$784.70M | n/m |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$388.64M | n/m |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$655.26M | n/m |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $588.82M | n/m |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $905.75M | n/m |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $245.91M | +57.6% |
Compare UTHR, BMRN, ALNY, PRGO side by side · Screen every company in Pharmaceutical Preparations ↗